Categories: Latest

South India’s largest COVID testing company now enters Bengaluru

Home sample collection service to be made available 

Bengaluru, September 21, 2020: Close on the heels of receiving the approval for conducting COVID-19 test at its reference lab in Chennai, Medall Diagnostics, India’s largest integrated diagnostic services provider, today announced the receipt of approval from ICMR for conducting the COVID tests at its Bengaluru facility.  Medall lab, with NABL accreditation, has the capacity to conduct 1500 tests per day in Bengaluru. Currently, this facility is available at its Sadashivnagar and Jayanagar centers. In the interest of the safety of patients, Medall will also be offering a home collection facility of samples.

Mr. Arjun Ananth, CEO, Medall Healthcare Private Limited said, “As the virus continues to spread globally, State Governments have put in place various measures to control the further spread of the pandemic. With 2 lakh cases and rising by the day, the approval from ICMR for COVID-19 testing in Bengaluru has come in at the right time reinforcing our commitment to offering qualitative diagnostic and healthcare services. At this point in time, Medall is well prepared to extend support to the Government of Karnataka in this pandemic situation and resolving anxiety amongst the public. Medall is already offering services to corporates for conducting health check-ups for employees before they resume work”.

 Medall offers COVID Monitoring tests including D-Dimer, Ferritin, IL-6 and Screening tests including RT-PCR, Antibody and Antigen and HRCT chest with CT severity score and CORADS staging. As per the guidelines issued by ICMR for Covid-19 testing in private laboratories, Medall will provide the test adhering to the sample collection and testing guidelines set by ICMR. 

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

31 mins ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

18 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

3 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago